13G filed by Bain Capital Life Sciences Opportunities IV, L.P.
Bain Capital Life Sciences Opportunities IV, L.P. reported 14,825,625 ADCT shares, 9.99% of the class, as of 2026-10-22, in a 13G accepted by EDGAR 2026-10-29 21:45:34 UTC.
- Accession
- 0001193125-26-438199
- Filer
- CIK 2015553
- Filed
- 2026-10-29
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- ADCT · ADC Therapeutics SA
- Shares
- 14,825,625
- Percent of class
- 9.99%
- Event date
- 2026-10-22
How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.
Read for the filer group Bain Capital Life Sciences Investors, LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Opportunities IV, L.P. | PN | 0 | 14,825,625 | 0 | 14,825,625 | 14,825,625 | 9.99% |